Neutron-activated, plasmonically excitable Fe-Pt-Yb 2 O 3 nanoparticles delivering anti-cancer radiation against human glioblastoma cells.

MLA

Seemann, Klaus M., et al. “Neutron-Activated, Plasmonically Excitable Fe-Pt-Yb 2 O 3 Nanoparticles Delivering Anti-Cancer Radiation against Human Glioblastoma Cells.” IScience, vol. 26, no. 9, Aug. 2023, p. 107683. EBSCOhost, https://doi.org/10.1016/j.isci.2023.107683.

APA

Seemann, K. M., Kovács, A., Schmid, T. E., Ilicic, K., Multhoff, G., Dunin-Borkowski, R. E., Michelagnoli, C., Cieplicka-Oryńczak, N., Jana, S., Colombi, G., Jentschel, M., Schneider, C. M., & Kuhn, B. (2023). Neutron-activated, plasmonically excitable Fe-Pt-Yb 2 O 3 nanoparticles delivering anti-cancer radiation against human glioblastoma cells. IScience, 26(9), 107683. https://doi.org/10.1016/j.isci.2023.107683

Chicago

Seemann, Klaus M, András Kovács, Thomas E Schmid, Katarina Ilicic, Gabriele Multhoff, Rafal E Dunin-Borkowski, Caterina Michelagnoli, et al. 2023. “Neutron-Activated, Plasmonically Excitable Fe-Pt-Yb 2 O 3 Nanoparticles Delivering Anti-Cancer Radiation against Human Glioblastoma Cells.” IScience 26 (9): 107683. doi:10.1016/j.isci.2023.107683.